Showing 2,041 - 2,060 results of 8,597 for search 'effective dysfunction', query time: 0.18s Refine Results
  1. 2041
  2. 2042
  3. 2043

    Investigation of Autonomic Involvement with Facial Sympathetic Skin Response in Patients with Idiopathic Cervical Dystonia by Nur Turkmen, Muhammed Yildirim, Ebru Bilge Dirik, Sule Bilen

    Published 2025-04-01
    “…Additionally, the relationship between botulinum toxin dose and facial SSR amplitudes was found to be dose-independent, further supporting the absence of a dose-dependent effect on sudomotor function. Conclusion: Patients with ICD showed clinical and electrophysiologic evidence of sympathetic dysfunction, as assessed using Compass-31 and SSR, respectively. …”
    Get full text
    Article
  4. 2044

    Current perspectives on malnutrition and immunomodulators bridging nutritional deficiencies and immune health by Ashish Majumdar, Surendra Kumar Saraf, Chandrashekhar Sahu, Khushboo Verma, Priyanka Vishwakarma

    Published 2025-04-01
    “…This study investigates the complex association between malnutrition and immune dysfunction, and the role of immunomodulators in restoring immune function. …”
    Get full text
    Article
  5. 2045

    Pharmacological correction of pro- and anti-inflammatory cytokine induction and energy metabolism system state in patients with coronary heart disease and chronic heart failure by V. E. Malikov, M. A. Arzumanyan, O. P. Donetskaya

    Published 2011-10-01
    “…To investigate the associations between the severity of inflammatory reaction and bio-energetic insufficiency development in patients with coronary heart disease (CHD) and reduced cardiac contractility; to assess the effectiveness of the pharmacological correction of these disturbances. …”
    Get full text
    Article
  6. 2046

    Recent advances in targeting LRRK2 for Parkinson’s disease treatment by Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi

    Published 2025-07-01
    “…Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approaches, necessitating exploring alternative methods anchored on genetic factors, notably the leucine-rich repeat kinase 2 (LRRK2) gene. …”
    Get full text
    Article
  7. 2047
  8. 2048
  9. 2049

    Oral administration of Porphyromonas gingivalis to mice with diet-induced obesity impairs cognitive function associated with microglial activation in the brain by Kana Oue, Yosuke Yamawaki, Kazuhisa Ouhara, Eiji Imado, Tetsuya Tamura, Mitsuru Doi, Yoshitaka Shimizu, Mitsuhiro Yoshida, Noriyoshi Mizuno, Norimitsu Morioka, Takashi Kanematsu, Masahiro Irifune, Yukio Ago

    Published 2024-12-01
    “…Furthermore, depletion of microglia by PLX3397, a colony-stimulating factor 1 receptor inhibitor, ameliorated cognitive dysfunction.Conclusion These results suggest that microglia mediate periodontal infection-induced cognitive dysfunction in obesity.…”
    Get full text
    Article
  10. 2050
  11. 2051
  12. 2052

    The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer by Bo Han, Yongfeng Zhang, Xue Feng, Jun Yang, Baolin Wang, Jiang Fang, Zhigang Wang, Jun Zhu, Ge Niu, Youxiang Guo

    Published 2025-04-01
    “…Conversely, a diverse and balanced gut microbiome may confer protective effects against cancer through mechanisms such as the production of short-chain fatty acids and the enhancement of intestinal barrier integrity. …”
    Get full text
    Article
  13. 2053

    The Vascular Wall State and Microcirculation Parameters in Patients with Controlled and Uncontrolled Arterial Hypertension by V. I. Podzolkov, A. E. Bragina, D. U. Natkina, T. A. Safronova, N. N. Nebieridze, E. V. Podshibyakina

    Published 2019-09-01
    “…This may reflect the slower effect of antihypertensive therapy on the remodeling processes of large vessels in comparison with the microvasculature.…”
    Get full text
    Article
  14. 2054

    CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS by N. A. Karoli, A. P. Rebrov

    Published 2017-09-01
    “…Studies of endothelial dysfunction in patients with respiratory diseases have become relevant in recent years. …”
    Get full text
    Article
  15. 2055
  16. 2056
  17. 2057

    Sex-Specific Cardiovascular Protection in Developing Metabolic Syndrome: The Role of AMPK by Miroslava Kvandova, Anna Zemancikova, Andrea Berenyiova, Iveta Waczulikova, Silvia Magyarova, Andrea Micurova, Jozef Torok, Marian Grman, Lenka Tomasova, Anton Misak, Zuzana Vysoka, Martina Manikova, Milan Zvarik, Patrick Mydla, Jana Vlkovicova, Peter Balis, Angelika Puzserova

    Published 2025-07-01
    “…Our results suggest that MetS and related cardiovascular comorbidities in males are driven by oxidative stress, inflammation, and endothelial dysfunction, with minimal additive effect of AMPK. In females, MetS arose only when inhibition of AMPK impaired estrogen signalling, emphasising their protective roles. …”
    Get full text
    Article
  18. 2058

    LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling by Xianghong Xie, Mingyue Gao, Wei Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo, Minglong Zhang, Ebenezeri Erasto Ngowi, Heping Wang, Xiaoman Wang, Yinghan Zhu, Yiting Wang, Xiaolu Li, Hong Yao, Li Yan, Fude Fang, Meixia Li, Aijun Qiao, Xiaojun Liu

    Published 2024-10-01
    “…LncRNAs are involved in modulating the individual risk and the severity of progression in metabolic dysfunction-associated fatty liver disease (MASLD), but their precise roles remain largely unknown. …”
    Get full text
    Article
  19. 2059

    Comparative analysis of two multitask approaches to cognitive training in cardiac surgery patients by I. V. Tarasova, I. N. Kukhareva, T. B. Temnikova, D. S. Kupriyanova, I. D. Syrova, А. S. Sosnina, O. A. Trubnikova, O. L. Barbarash

    Published 2024-04-01
    “…Reexamination with assessment of postoperative cognitive dysfunction (POCD) was carried out on days 2-3 and upon completion of 5-7 days of training or on days 11-12 after CABG.Results. …”
    Get full text
    Article
  20. 2060